Update in Antiepidermal Growth Factor Receptor Therapy in the Management of Metastatic Colorectal Cancer
Joint Authors
Ma, Brigette B.
Chan, Anthony T. C.
Loong, Herbert H.
Source
Issue
Vol. 2009, Issue 2009 (31 Dec. 2009), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2009-04-09
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
The approval of anti-epidermal growth factor receptor (EGFR) monoclonal antibodies in the treatment of metastatic colorectal cancer (CRC) has expanded the armamentarium against this disease.
This paper will review the historical progress and recent clinical developments of anti-EGFR therapies in the treatment of metastatic CRC.
Novel strategies of targeting the EGFR pathway to improve efficacy as well as ongoing research in identifying specific molecular predictors of response will be discussed.
American Psychological Association (APA)
Loong, Herbert H.& Ma, Brigette B.& Chan, Anthony T. C.. 2009. Update in Antiepidermal Growth Factor Receptor Therapy in the Management of Metastatic Colorectal Cancer. Journal of Oncology،Vol. 2009, no. 2009, pp.1-6.
https://search.emarefa.net/detail/BIM-512157
Modern Language Association (MLA)
Loong, Herbert H.…[et al.]. Update in Antiepidermal Growth Factor Receptor Therapy in the Management of Metastatic Colorectal Cancer. Journal of Oncology No. 2009 (2009), pp.1-6.
https://search.emarefa.net/detail/BIM-512157
American Medical Association (AMA)
Loong, Herbert H.& Ma, Brigette B.& Chan, Anthony T. C.. Update in Antiepidermal Growth Factor Receptor Therapy in the Management of Metastatic Colorectal Cancer. Journal of Oncology. 2009. Vol. 2009, no. 2009, pp.1-6.
https://search.emarefa.net/detail/BIM-512157
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-512157
